Opioid prescribing trends and pain scores among adult patients with cancer in a large health system
Open Access
Abstract
Background: Opioid stewardship policies could adversely affect pain management for patients with cancer. Yet patients with cancer are also at risk for opioid‐related harms. This study sought to determine trends in opioid prescribing by clinical stratum and pain for patients with cancer from 2016 to 2020. Methods: A retrospective study was conducted of opioid‐naive adults with newly diagnosed cancer from 2016 to 2020 ( N = 10,232) in a large Connecticut health system. Logistic regression was used to calculate changes in the predicted probability of opioid prescribing from 2016 to 2020. Two subpopulations were examined: patients treated surgically ( n = 4405) and patients with metastatic cancer ( n = 2158). Flowsheet pain scores for patients with metastatic cancer were used to stratify by no pain (all scores, 0) versus any pain. The main outcomes were new (≥1 prescription in the 0–6 months after diagnosis) and additional (0–6 and 7–9 months) opioid prescriptions. Results: A decline was observed in the predicted probability of new (71.1% to 64.6%; p < .001) and additional prescribing (27.2% to 24.2%; p = .07 [not significant]) declined. Among surgical patients, the predicted probability of new opioid prescribing fell (96.0% to 88.6%; p < .001), whereas additional prescribing was stable (13%). For patients with metastatic cancer with pain, new opioid prescribing was stable (56%). For those reporting no pain, the predicted probability of new opioid prescribing declined from 61.6% to 36.1% ( p < .001). Conclusions: In the context of widespread policy changes, this study showed a modest decline in new and additional opioid prescribing for patients with cancer. In metastatic cancer, prescribing remained stable for patients reporting pain and declined steeply for those reporting no pain.Keywords
Funding Information
- U.S. Food and Drug Administration (U01FD005938)
This publication has 43 references indexed in Scilit:
- Adapting the Elixhauser comorbidity index for cancer patientsCancer, 2018
- New Persistent Opioid Use Among Patients With Cancer After Curative-Intent SurgeryJournal of Clinical Oncology, 2017
- Risk Factors for Opioid-Use Disorder and OverdoseAnesthesia & Analgesia, 2017
- Evaluating the Risks of Opioid Use for Chronic Pain: Moving Beyond OverdoseJournal of General Internal Medicine, 2016
- State-level and system-level opioid prescribing policies: The impact on provider practices and overdose deaths, a systematic reviewJournal of Opioid Management, 2016
- Assessing Risk for Drug Overdose in a National Cohort: Role for Both Daily and Total Opioid Dose?The Journal of Pain, 2015
- A systematic review identifies valid comorbidity indices derived from administrative health dataJournal of Clinical Epidemiology, 2015
- A comparison of charlson and elixhauser comorbidity measures to predict colorectal cancer survival using administrative health dataCancer, 2010
- Cancer Pain: An Age-Based AnalysisPain Medicine, 2010
- Comorbidity Measures for Use with Administrative DataMedical Care, 1998